Stevanato Group SpA 87N
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €17.10
- Day Range
- €16.90–17.30
- 52-Week Range
- €11.30–—
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 273.13M
- Market Cap
- €4.70B
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 33.32
- Price/Sales
- 3.83
- Dividend Yield (Trailing)
- 0.31%
- Dividend Yield (Forward)
- 0.31%
- Dividend Payment Schedule
- Jul
- Total Yield
- 0.31%
Company Profile
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 5,795
- Website
- https://www.stevanatogroup.com
Competitors
Valuation
|
Metric
|
87N
|
YPSN
|
WST
|
|---|---|---|---|
Price/Earnings (Normalized) | 33.32 | 27.38 | 43.06 |
Price/Book Value | 3.03 | 6.36 | 8.62 |
Price/Sales | 3.83 | 6.74 | 7.95 |
Price/Cash Flow | 18.55 | 19.25 | 34.46 |
Price/Earnings
87N
YPSN
WST
Financial Strength
|
Metric
|
87N
|
YPSN
|
WST
|
|---|---|---|---|
Quick Ratio | 1.08 | 0.74 | 1.79 |
Current Ratio | 1.61 | 1.07 | 2.82 |
Interest Coverage | 33.87 | 76.55 | 150.98 |
Quick Ratio
87N
YPSN
WST
Profitability
|
Metric
|
87N
|
YPSN
|
WST
|
|---|---|---|---|
Return on Assets (Normalized) | 6.21% | 13.64% | 14.96% |
Return on Equity (Normalized) | 10.50% | 23.71% | 20.28% |
Return on Invested Capital (Normalized) | 8.24% | 18.06% | 18.06% |
Return on Assets
87N
YPSN
WST
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|C?NS$B%p | LOCK|M&y | $150B | |||
| Becton Dickinson & Co
BDX
| LOCK|MQ$ | LOCK|qs?dR | $50B | |||
| ResMed Inc
RMD
| LOCK|t@D?J<% | LOCK|@^j? | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|r%BK^v | LOCK|TB>r | $32B | |||
| Alcon Inc
ALC
| LOCK|PMp<#pZ | LOCK|<T%% | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|wLmkkyy$ | LOCK|%d | $26B | |||
| Solventum Corp
SOLV
| LOCK|sGxzDW | LOCK|X> | $15B | |||
| Baxter International Inc
BAX
| LOCK|@ks | LOCK|tqQB | $13B | |||
| Repligen Corp
RGEN
| LOCK|v>hRTh@? | LOCK|qb$L | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|TTphRk | LOCK|DB!$^ | $10B |
United States